PLATINUM-REFRACTORY FALLOPIAN TUBE CARCINOMA

Clinical trials for PLATINUM-REFRACTORY FALLOPIAN TUBE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PLATINUM-REFRACTORY FALLOPIAN TUBE CARCINOMA trials appear

Sign up with your email to follow new studies for PLATINUM-REFRACTORY FALLOPIAN TUBE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Modified virus attacks tough ovarian cancer in new trial

Disease control Recruiting now

This early-stage trial is testing whether a specially engineered virus called TILT-123, when combined with existing cancer drugs, is safe and potentially effective for women with advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The virus is d…

Matched conditions: PLATINUM-REFRACTORY FALLOPIAN TUBE CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PLATINUM-REFRACTORY FALLOPIAN TUBE CARCINOMA

Get alerted when new PLATINUM-REFRACTORY FALLOPIAN TUBE CARCINOMA trials appear

Modified virus attacks tough ovarian cancer in new trial